Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SU vs GSK✓SelectedUSD · GSKSU vs GSK performance historyLatest closeAs of-2.80%11/16
Stock and ETF performance explorer

SU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+61,820.3%
GSK return
+1,741.1%
Excess return
+60,079.2%
Maximum drawdown
-86.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.7%-2.8%
7D+0.8%-1.3%+2.1%+1.3%
30D-12.9%+2.7%-15.7%-14.0%
3M+3.9%+2.7%+1.2%+2.2%
6M+0.8%+3.3%-2.5%-1.5%
YTD+56.4%+6.5%+49.9%+49.6%
1Y+56.4%+10.7%+45.7%+47.3%
3Y+131.4%+64.4%+67.0%+80.9%
5Y+221.3%+46.7%+174.6%+158.3%
10Y+216.5%+109.4%+107.1%+121.4%
All+61,820.3%+1,741.1%+60,079.2%+15,968.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling